Canada receives J&J's COVID-19 vaccine from plant where FDA halted production
Reuters
Published Apr 30, 2021 20:55
(Reuters) -Canada's drug regulator said on Friday that doses of Johnson & Johnson (NYSE:JNJ)'s COVID-19 vaccine recently delivered to the country were produced at a Baltimore plant where the U.S. Food and Drug Administration (FDA) halted production.
Health Canada said in a statement that it will hold the vaccine doses until it is satisfied they meet its standards, and is consulting with J&J and the FDA. The first shipment of 300,000 J&J vaccine doses arrived in Canada earlier this week.
The FDA halted production of the vaccines at a U.S. manufacturing plant owned by Emergent BioSolutions earlier this month as it investigates an error that led to millions of doses being ruined in March.
Late on Friday, Health Canada said it had learned that the active ingredient in the vaccine had been made at the Emergent site, and the final vaccines were manufactured at a different site outside the United States.
J&J was not available for immediate comment.
Many COVID-19 vaccines are made at one site and packaged into vials at another site.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.